detail
data
lack
influenza
burden
unit
kingdom
uk
object
studi
estim
diseas
burden
associ
influenzalik
ill
ili
unit
kingdom
stratifi
age
risk
influenza
vaccin
statu
retrospect
crosssect
exploratori
observ
studi
use
link
data
gener
practic
research
databas
hospit
episod
statist
databas
estim
resourc
use
cost
associ
ili
uk
data
includ
patient
gener
practition
visit
ili
highrisk
patient
vaccin
vaccin
lowrisk
patient
vaccin
vaccin
highrisk
vaccin
patient
older
p
risk
condit
p
highrisk
odd
ratio
vaccin
patient
higher
probabl
gener
practition
visit
compar
lowrisk
unvaccin
patient
patient
highrisk
vaccin
reduc
risk
gener
practition
visit
p
highrisk
individu
also
vaccin
lower
probabl
ilirel
hospitalis
individu
highrisk
vaccin
alon
peopl
age
year
mortal
rate
lower
vaccin
unvaccin
individu
cost
ilirel
gp
visit
hospit
admiss
uk
studi
period
lowrisk
vaccin
patient
respect
lowrisk
unvaccin
patient
correspond
valu
respect
influenza
case
gener
virolog
confirm
routin
uk
clinic
practic
influenza
ili
rare
record
specif
medic
note
thu
neither
specif
diagnosi
influenzaili
virolog
confirm
influenza
could
use
select
method
gener
practic
research
databas
gprd
code
gener
practition
gp
consult
use
clinic
read
code
proport
patient
gprd
link
data
hospit
episod
statist
he
dataset
link
patient
repres
whole
gprd
popul
sinc
studi
initi
gprd
chang
name
known
clinic
practic
research
datalink
cprd
data
patient
least
one
gp
consult
read
code
describ
influenza
acut
upper
lower
respiratori
tract
infect
ili
extract
link
gprdhe
dataset
period
st
januari
st
march
inclus
consult
code
read
code
occur
period
peak
influenza
circul
attribut
ili
file
consult
code
specif
read
code
occur
period
peak
influenza
circul
attribut
ili
peak
influenza
period
week
influenza
influenza
b
circul
identifi
regress
analysi
surveil
data
circul
influenza
respiratori
pathogen
obtain
uk
health
protect
agenc
hpa
period
novemb
decemb
use
techniqu
pitman
et
al
describ
patient
gp
consult
code
relev
read
code
influenza
period
includ
studi
also
minimum
day
observ
index
event
least
year
observ
diagnosi
patient
stratifi
age
group
year
year
year
year
year
risk
statu
highrisk
defin
nation
institut
health
care
excel
depart
health
criteria
lowrisk
influenza
vaccin
statu
patient
categoris
vaccin
record
influenza
vaccin
winter
flu
season
index
episod
data
gp
consult
hospit
admiss
extract
link
gprd
he
dataset
file
two
gp
consult
record
patient
day
one
count
data
observ
day
gp
consult
identifi
hospit
admiss
influenza
complic
follow
influenza
first
episod
hospitalis
retain
dataset
like
relat
caus
admiss
rather
subsequ
complic
mortal
data
identifi
link
gprdhe
dataset
mortal
record
gp
hospit
discharg
popul
estim
obtain
offic
nation
statist
on
use
midyear
estim
resid
popul
surveil
data
circul
influenza
respiratori
infect
obtain
uk
hpa
period
novemb
decemb
group
flu
week
period
approxim
week
data
mismatch
influenza
vaccin
circul
influenza
viru
strainslineag
obtain
hpa
primari
outcom
measur
mortal
resourc
use
gp
consult
hospit
admiss
read
code
relat
episod
includ
cost
associ
influenza
primari
secondari
care
stratifi
age
group
complic
statu
vaccin
statu
risk
statu
paper
present
data
vaccin
uptak
resourc
use
cost
mortal
vaccin
statu
degre
mismatch
result
studi
publish
elsewher
watkin
et
al
prepar
medic
prescrib
limit
includ
item
antipyret
analges
antivir
nasal
decongest
antihistamin
antibiot
furthermor
encount
relat
episod
includ
analysi
routin
visit
unrel
encount
exclud
unit
cost
hospitalis
gp
consult
outpati
visit
obtain
person
social
servic
research
unit
databas
resourc
use
data
combin
unit
cost
data
estim
total
cost
perspect
uk
nation
health
servic
cost
express
pound
sterl
use
cost
regress
analysi
use
estim
proport
gp
consult
hospitalis
death
potenti
attribut
pathogen
use
techniqu
pitman
et
al
previous
describ
ryan
et
al
observ
tempor
trend
laboratori
confirm
report
agent
could
potenti
caus
influenzaacut
respiratori
infectionili
compar
number
event
consider
gp
consult
hospit
episod
mortal
time
period
latter
use
depend
variabl
multipl
regress
independ
variabl
weekli
number
nation
laboratori
report
hpa
data
adenoviru
coronaviru
influenza
influenza
b
mycoplasma
pneumonia
parainfluenza
respiratori
syncyti
viru
rhinoviru
laboratori
report
age
stratifi
would
result
individu
certain
class
method
linear
regress
use
number
laboratori
report
pathogen
week
j
l
ij
background
number
nation
laboratori
report
estim
regress
coeffici
j
fit
equat
j
c
l
ij
j
indic
independ
variabl
weekli
number
nation
laboratori
report
aggreg
age
group
multivari
regress
assum
normal
error
term
perform
initi
model
includ
organ
explanatori
variabl
signific
organ
assess
p
valu
variabl
signific
result
coeffici
neg
biolog
implaus
variabl
discard
model
valid
final
model
assess
term
proport
variat
explain
r
signific
joint
relationship
observ
independ
variabl
model
ie
probabl
r
differ
significantli
zero
impact
chang
model
specif
regress
analysi
use
assess
relationship
burden
degre
mismatch
influenza
vaccin
circul
influenza
viru
strain
year
multivari
analysi
use
uncov
structur
within
data
factor
contribut
excess
burden
base
knowledg
sourc
data
obtain
process
generalis
linear
model
fit
characteris
associ
baselin
characterist
burden
vaccin
unvaccin
patient
categoris
highrisk
compar
use
independ
sampl
ttest
age
number
risk
condit
test
variabl
similar
analysi
undertaken
patient
categoris
highrisk
use
age
test
variabl
extrapol
databas
sampl
total
uk
popul
multipli
factor
calcul
annual
averag
total
uk
popul
studi
period
use
on
midyear
estim
resid
popul
annual
averag
number
patient
link
gprdhe
databas
popul
calcul
gprdhe
data
extract
divid
databas
popul
total
uk
popul
give
multipli
factor
result
databas
multipli
factor
estim
total
burden
whole
uk
factor
use
patient
group
agespecif
complicationspecif
riskspecif
popul
avail
adjust
demograph
made
link
dataset
includ
patient
least
one
gp
consult
ili
defin
describ
method
mean
age
year
women
demograph
characterist
studi
popul
publish
elsewher
watkin
et
al
prepar
tabl
show
breakdown
gener
physician
visit
read
code
tabl
show
percentag
patient
risk
group
vaccin
year
elderli
patient
age
year
highest
uptak
rate
uptak
rate
gener
increas
begin
end
studi
period
risk
group
highrisk
group
mean
age
vaccin
group
year
standard
deviat
sd
compar
year
sd
unvaccin
group
p
mean
number
risk
condit
vaccin
group
sd
compar
sd
unvaccin
group
p
patient
without
risk
condit
vaccin
patient
also
older
unvaccin
patient
mean
year
sd
compar
mean
year
sd
p
vaccin
patient
therefor
statist
significantli
differ
unvaccin
patient
older
risk
condit
taken
account
consid
outcom
differ
group
tabl
show
number
cost
ilirel
hospit
admiss
gp
consult
outpati
visit
lowrisk
patient
vaccin
complic
statu
data
absolut
number
ilirel
admiss
gp
consult
outpati
visit
found
tabl
data
hospit
admiss
stratifi
rout
admiss
via
accid
emerg
gp
referr
rout
found
tabl
lowrisk
patient
unvaccin
patient
use
gp
outpati
resourc
vaccin
patient
reflect
larg
number
unvaccin
lowrisk
case
databas
secondari
care
resourc
use
evenli
split
slightli
higher
total
resourc
use
cost
group
vaccin
patient
group
unvaccin
patient
consist
older
age
vaccin
patient
compar
unvaccin
group
extrapol
uk
cost
ilirel
gp
visit
hospit
admiss
studi
period
lowrisk
vaccin
patient
respect
lowrisk
unvaccin
patient
correspond
valu
respect
secondari
care
resourc
use
concentr
case
influenza
complic
record
regardless
vaccin
statu
tabl
show
number
cost
ilirel
hospit
admiss
gp
consult
outpati
visit
highrisk
patient
vaccin
complic
statu
data
absolut
number
ilirel
admiss
gp
consult
outpati
visit
found
tabl
data
hospit
admiss
stratifi
rout
admiss
via
accid
emerg
gp
referr
rout
found
tabl
highrisk
patient
group
vaccin
patient
use
resourc
primari
secondari
care
compar
group
unvaccin
patient
consist
older
age
higher
number
risk
condit
vaccin
unvaccin
patient
case
lowrisk
patient
secondari
care
resourc
use
concentr
case
influenza
complic
record
regardless
vaccin
statu
extrapol
uk
cost
ilirel
gp
visit
hospit
admiss
studi
period
highrisk
vaccin
patient
respect
highrisk
unvaccin
patient
correspond
valu
respect
tabl
show
number
ilirel
death
vaccin
statu
overal
death
observ
vaccin
unvaccin
patient
consist
systemat
differ
vaccin
unvaccin
individu
vaccin
individu
older
fragil
risk
condit
unvaccin
individu
howev
among
group
age
year
mortal
rate
among
vaccin
individu
odd
ratio
confid
interv
ci
p
lower
unvaccin
individu
age
categori
age
categori
respect
tabl
tabl
show
circul
viru
strain
influenza
b
vaccin
lineag
degre
match
vaccin
circul
b
lineag
year
studi
hpa
data
mismatch
vaccin
circul
influenza
b
viru
lineag
five
ten
year
two
influenza
b
lineag
cocircul
three
ten
year
season
also
high
circul
influenza
b
influenza
b
account
circul
influenza
season
trend
influenza
b
mismatch
season
associ
peak
ilirel
gp
visit
fig
season
highest
mismatch
highest
influenza
b
circul
clearli
associ
peak
ilirel
gp
visit
fig
highest
rate
ilirel
death
occur
second
highest
influenza
b
mismatch
season
fig
ilirel
hospit
admiss
show
similar
pattern
fig
hospit
admiss
highli
correl
gp
visit
correl
coeffici
influenza
influenza
b
other
mortal
highli
correl
hospitalis
correl
coeffici
influenza
b
influenza
other
tabl
show
logist
regress
coeffici
likelihood
gp
visit
hospit
admiss
mortal
highrisk
patient
patient
vaccin
higher
probabl
ilirel
gp
visit
compar
highrisk
vaccin
vaccin
patient
ci
p
highrisk
patient
ci
p
howev
interact
patient
highrisk
vaccin
reduc
risk
gp
visit
ci
p
appar
age
interact
effect
relev
age
group
highrisk
individu
also
vaccin
lower
probabl
ilirel
hospitalis
individu
highrisk
vaccin
alon
ci
p
year
influenza
b
mismatch
statist
signific
increas
odd
hospit
admiss
ci
p
patient
highrisk
higher
probabl
ilirel
death
studi
period
ci
p
patient
vaccin
lower
probabl
death
studi
period
ci
p
present
studi
build
previou
investig
burden
ili
uk
sever
way
knowledg
first
time
link
primari
care
hospit
databas
use
estim
burden
ili
furthermor
first
studi
report
quantit
data
ili
burden
complic
statu
complic
record
without
complic
record
age
risk
vaccin
statu
influenza
vaccin
uptak
increas
studi
period
vaccin
still
fail
reach
peopl
age
year
older
england
target
rate
influenza
vaccin
peopl
age
year
atrisk
group
increas
studi
indic
vaccin
uptak
rate
achiev
elderli
popul
close
target
rang
howev
vaccin
uptak
rate
atrisk
group
gener
exceedingli
low
compar
target
except
condit
diabet
renal
diseas
improv
vaccin
uptak
rate
younger
age
group
risk
condit
improv
vaccin
uptak
elderli
may
potenti
reduc
consider
burden
ili
uk
analysi
demonstr
vaccin
highrisk
individu
better
outcom
highrisk
unvaccin
individu
ili
case
occur
individu
categoris
highrisk
vaccin
patient
visit
gp
admit
hospit
studi
popul
estim
cost
million
million
respect
scale
whole
uk
popul
would
equival
million
gp
visit
million
hospit
admiss
rais
possibl
mass
annual
vaccin
could
potenti
medic
econom
benefit
reduc
burden
influenza
case
individu
group
current
target
vaccin
univers
influenza
vaccin
introduc
ontario
canada
associ
reduct
influenzarel
mortal
healthcar
use
compar
target
vaccin
programm
provinc
suggest
mass
vaccin
could
costsav
usa
vaccin
patient
differ
significantli
unvaccin
patient
older
risk
condit
pattern
well
known
expect
current
govern
polici
target
elderli
andor
highrisk
group
influenza
vaccin
consist
observ
pattern
higher
resourc
use
vaccin
patient
highrisk
group
present
studi
sinc
vaccin
individu
older
risk
condit
unvaccin
individu
like
fragil
health
thu
need
healthcar
vaccin
unvaccin
group
significantli
differ
outcom
directli
compar
data
interpret
caution
popul
vaccin
unvaccin
group
could
compar
subgroup
age
year
older
accord
current
polici
individu
age
group
receiv
season
influenza
vaccin
among
group
ilirel
mortal
rate
among
vaccin
individu
lower
mortal
rate
among
unvaccin
individu
consist
protect
effect
influenza
vaccin
effect
size
similar
report
previou
studi
popul
group
report
reduct
hospitalis
hospitalis
acut
chronic
respiratori
ill
allcaus
mortal
multivari
analysi
indic
patient
categoris
highrisk
disproportion
risk
hospitalis
howev
highrisk
individu
also
vaccin
lower
risk
hospitalis
individu
highrisk
alon
similarli
patient
highrisk
higher
probabl
gp
visit
wherea
patient
highrisk
vaccin
lower
probabl
gp
visit
find
suggest
vaccin
may
help
reduc
risk
hospitalis
addit
gp
visit
highrisk
group
demonstr
clear
benefit
vaccin
highrisk
individu
rational
ensur
coverag
group
individu
reinforc
coverag
younger
year
target
low
vaccin
coverag
place
individu
risk
seriou
complic
death
vaccin
influenza
howev
although
result
show
clearli
vaccin
highrisk
patient
databas
lower
rate
addit
gp
visit
hospitalis
unvaccin
highrisk
patient
databas
may
potenti
confound
differ
healthseek
behaviour
could
captur
databas
account
analysi
exampl
survey
adult
asthma
parent
highrisk
children
singl
uk
gp
practic
identifi
lack
awar
barrier
access
health
belief
factor
influenc
influenza
vaccin
uptak
factor
could
potenti
confound
result
also
affect
patient
readi
seek
treatment
exampl
patient
wait
sever
symptom
develop
present
medic
attent
may
requir
higher
level
intervent
patient
present
earli
analysi
would
abl
identifi
potenti
confound
factor
limit
studi
recent
casecontrol
studi
use
gprd
data
peopl
low
risk
influenza
uk
found
influenza
vaccin
reduc
risk
influenza
ci
given
within
month
season
influenza
outbreak
howev
despit
author
attempt
minimis
confound
identifi
residu
confound
effect
group
peopl
studi
annual
vaccin
multipl
year
also
consist
like
develop
influenza
receiv
fewer
annual
vaccin
may
indic
group
predispos
medic
condit
made
simultan
like
seek
influenza
vaccin
also
higher
risk
influenza
per
assumpt
circul
data
hpa
reflect
strain
circul
commun
limit
studi
influenza
b
gp
visit
hospitalis
death
show
peak
influenza
season
high
influenza
b
activ
vaccin
mismatch
correl
coeffici
show
influenza
b
death
close
correl
hospitalis
hospitalis
gp
visit
influenza
respiratori
infect
hospitalis
close
correl
gp
visit
death
hospitalis
multivari
analysi
also
show
statist
signific
increas
odd
hospitalis
year
vaccin
influenza
b
mismatch
season
mismatch
vaccin
lineag
circul
influenza
lineag
individu
may
receiv
less
clinic
benefit
vaccin
anticip
vaccin
provid
limit
protect
mismatch
viru
lineag
suggest
improv
vaccin
protect
influenza
b
mismatch
year
could
valu
quadrival
influenza
vaccin
provid
protect
influenza
b
lineag
start
cocircul
recent
year
therefor
improv
protect
note
mismatch
analysi
depend
implicit
assumpt
hpa
surveil
data
repres
case
respiratori
infect
seen
gp
practic
hospit
nation
howev
hpa
data
deriv
sentinel
practic
may
differ
gener
pool
gp
practic
gprd
data
deriv
possibl
use
hpa
data
attribut
case
variou
respiratori
virus
could
overor
underestim
proport
infect
due
pathogen
limit
studi
limit
studi
complic
statu
assess
accord
whether
complic
record
databas
patient
complic
record
could
potenti
miscod
influenza
without
complic
explor
possibl
investig
full
record
small
number
patient
admit
hospit
despit
complic
influenza
record
databas
show
although
patient
secondari
diagnosi
code
therefor
class
complic
fact
complic
pneumonia
respiratori
manifest
code
error
form
natur
limit
retrospect
databas
studi
even
comprehens
databas
captur
possibl
inform
data
like
underestim
true
burden
ili
uk
year
includ
studi
happen
year
low
influenza
activ
present
primari
public
watkin
et
al
prepar
data
would
also
identifi
hospitalacquir
influenza
infect
furthermor
previou
research
indic
hospitalis
influenza
may
trigger
longterm
health
declin
elderli
patient
studi
attempt
take
effect
account
studi
provid
detail
quantit
data
date
ili
burden
uk
help
narrow
consider
uncertainti
model
potenti
impact
intervent
result
indic
although
vaccin
rate
target
group
increas
studi
period
substanti
proport
peopl
still
receiv
influenza
vaccin
improv
uptak
influenza
vaccin
among
elderli
peopl
highrisk
group
potenti
achiev
substanti
health
benefit
support
inform
file
read
code
code
docx
tabl
absolut
valu
resourc
use
cost
lowrisk
highrisk
patient
public
manag
manuscript
coordin
behalf
glaxosmithklin
biolog
sa
